dacarbazine has been researched along with Erythema in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ladizinski, B; Sankey, C | 1 |
| Curi Tuma, M; Salazar Gangas, C; Sandoval Osses, M | 1 |
| Baumgart, U; Bogdahn, U; Hau, P; Hirschmann, B; Kunz-Schughart, L; Muhleisen, H; Reichle, A; Ruemmele, P; Steinbrecher, A; Weimann, E | 1 |
| Lefebvre, PJ; Luyckx, AS | 1 |
| Aliaga, A; Camps, C; Febrer, I; Godes, M; Pujol, C; Serrano, G | 1 |
| Altimari, AF; Bhoopalam, N; Lange, CL; O'Dorsio, T; Prinz, RA; Sandberg, L | 1 |
| Lambers, JC; Lambrecht, ER; van der Loos, TL | 1 |
1 review(s) available for dacarbazine and Erythema
| Article | Year |
|---|---|
[The glucagonomas (author's transl)].
Topics: Adenoma, Islet Cell; Adult; Aged; Amino Acids; Anemia; Arginine; Body Weight; Cholesterol; Dacarbazine; Diabetes Mellitus; Diagnosis, Differential; Erythema; Female; Glossitis; Glucagon; Glucagonoma; Humans; Hypoproteinemia; Male; Middle Aged; Nervous System Diseases; Pancreatic Neoplasms; Somatostatin; Streptozocin; Thrombophlebitis; Zinc | 1981 |
1 trial(s) available for dacarbazine and Erythema
| Article | Year |
|---|---|
Low-dose chemotherapy in combination with COX-2 inhibitors and PPAR-gamma agonists in recurrent high-grade gliomas - a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neoplasms; Capecitabine; Cyclooxygenase 2 Inhibitors; Dacarbazine; Deoxycytidine; Drug Administration Schedule; Edema; Efferent Pathways; Erythema; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Glioblastoma; Glioma; Humans; Immunohistochemistry; Lactones; Male; Middle Aged; Neoplasm Recurrence, Local; Neovascularization, Pathologic; Pioglitazone; PPAR gamma; Predictive Value of Tests; Quality of Life; Sulfones; Temozolomide; Thiazolidinediones; Treatment Outcome | 2007 |
5 other study(ies) available for dacarbazine and Erythema
| Article | Year |
|---|---|
A topical matter: toxic epidermal necrolysis.
Topics: Acetaminophen; Analgesics, Opioid; Anti-Inflammatory Agents; Anticonvulsants; Antiemetics; Antineoplastic Agents; Dacarbazine; Dexamethasone; Drug Combinations; Erythema; gamma-Globulins; Glioblastoma; Humans; Immunologic Factors; Levetiracetam; Male; Methylprednisolone; Middle Aged; Omeprazole; Oxycodone; Piperidines; Piracetam; Proton Pump Inhibitors; Quinazolines; Stevens-Johnson Syndrome; Temozolomide; Wound Healing | 2014 |
[Flagellate erythema].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Eruptions; Erythema; Hodgkin Disease; Humans; Male; Middle Aged; Vinblastine | 2014 |
Dacarbazine-induced photosensitivity.
Topics: Dacarbazine; Edema; Erythema; Facial Dermatoses; Female; Humans; Leiomyosarcoma; Middle Aged; Photosensitivity Disorders; Uterine Neoplasms | 1989 |
Use of a somatostatin analog (SMS 201-995) in the glucagonoma syndrome.
Topics: Adenoma, Islet Cell; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Diabetes Mellitus; Drug Evaluation; Erythema; Female; Fluorouracil; Glucagon; Glucagonoma; Humans; Liver Neoplasms; Male; Middle Aged; Octreotide; Pancreatic Neoplasms; Somatostatin; Streptozocin; Syndrome | 1986 |
Successful treatment of glucagonoma-related necrolytic migratory erythema with dacarbazine.
Topics: Adenoma, Islet Cell; Dacarbazine; Erythema; Glucagonoma; Humans; Male; Middle Aged; Pancreatic Neoplasms | 1987 |